Maternal PKU: Pharmaceutical and other advancements | Webinar Recording
Tuesday 6th December 2022
Description
Two Metabolic Nutritionists discuss the impact that pharmaceutical interventions are having on MPKU management, with an update on sapropterin usage in MPKU and a review of the first case studies on pegvaliase usage during pregnancy.
Learning Objectives
- To understand how new therapies (e.g. protein substitutes/medical foods, sapropterin, pegvaliase) have impacted management of PKU in pregnancy (MPKU) and lactation.
- To be able to describe how the use of pegvaliase may be initiated and managed in MPKU from presented case studies.
